Skip to main content

Osteoarthritis

    RT @Janetbirdope: Since MTX doesn’t work in cardiac prevention in non inflammatory pop’n (CIRT trial) should we use
    3 years 4 months ago
    Since MTX doesn’t work in cardiac prevention in non inflammatory pop’n (CIRT trial) should we use MTX in knee OA with inflammation? RCT n=344 w primary knee OA w swelling & pain. Rx MTX v glucosamine POSITIVE results #ACR20 abstr#1648 @RheumNow @CRASCRRheum #ACRbest https://t.co/7VptCPxKU8
    RT @Janetbirdope: #osteoarthritis Rx with #tanezumab - analgesic or DMOAD? RCT in knee OA of 3021 pts & only 1312 co
    3 years 4 months ago
    #osteoarthritis Rx with #tanezumab - analgesic or DMOAD? RCT in knee OA of 3021 pts & only 1312 completed Rx. Tanezumab > improvement in pain v NSAIDs but NO diff in MCII and pt acceptable symptoms (PASS) over time #ACR20 #ACRbest abstr#1641 @RheumNow @CRASCRRheum https://t.co/x75ncz16uP
    CV Risk in Rheumatoid Arthritis and Osteoarthritis: Dr. Eric Dein

    Dr. Eric Dein reviews abstract #1189 (from the PRECISION trial) presented at the 2020 ACR annual meeting.

    RT @DrPetryna: #EULAR2020 #op0327 AI stages knee OA radiograpgic chsnges ieth accuracy 91.8-99% in 95% of the cases. Wou
    3 years 4 months ago
    #EULAR2020 #op0327 AI stages knee OA radiograpgic chsnges ieth accuracy 91.8-99% in 95% of the cases. Would you prefer AI or human radiology readings for MSK imaging ? @RheumNow
    RT @DrMiniDey: #Multimorbidity in #RheumaticDisease: Abs#1466:
    -Highly prevalent across RA, PsA, gout & OA
    -Highest
    3 years 4 months ago
    #Multimorbidity in #RheumaticDisease: Abs#1466: -Highly prevalent across RA, PsA, gout & OA -Highest burden in #gout Important study highlighting need to recognise burden of MM in #rheumatology patients for holistic optimised management. #ACR20 @RheumNow https://t.co/esinnHoUME https://t.co/bApXfx7hOU
    RT @RichardPAConway: Dr England presents on multimorbidity in RA, PsA, gout, and OA within RISE registry. Highly prevale
    3 years 4 months ago
    Dr England presents on multimorbidity in RA, PsA, gout, and OA within RISE registry. Highly prevalent in all 4 but most pronounced in gout and RA. Critical to recognise and manage. @rheumnow #ACR20 Abstr#1466 https://t.co/XtwIfJnVXV
    Warfarin and Risk of Hip and Knee Replacements: Dr. Mrinalini Dey

    Dr. Mrinalini Dey reviews abstract #0934 presented Saturday at the 2020 ACR annual meeting.

    Warfarin and End-Stage Osteoarthritis: Dr. David Liew

    Dr. David Liew discusses abstract #0934 presented at the 2020 ACR annual meeting.

    RT @drpnash: Liraglutide as a Potential Intra-Articular Treatment for Cartilage Regeneration in Osteoarthritis: In Vitro
    3 years 4 months ago
    Liraglutide as a Potential Intra-Articular Treatment for Cartilage Regeneration in Osteoarthritis: In Vitro and In Vivo Studies Supporting a Pro-Chondrogenic Effect https://t.co/T9IqF7E00Z #OA #DMOAD a potential DMOAD in mice
    RT @Tuhina_Neogi: @Janetbirdope @RheumNow @CRASCRRheum This study is a follow-on to an existing body of evidence re: vit
    3 years 4 months ago
    @Janetbirdope @RheumNow @CRASCRRheum This study is a follow-on to an existing body of evidence re: vitamin K-dependent proteins ("Gla" proteins) in #OA, as well as warfarin VK antagonist effects, and agnostic discovery in a GWAS. The findings hold including in studies unrelated to access to care and a small RCT.